Neuro Spinal Innovation

REVOLUTIONIZING PAIN TREATMENT

Neuro Spinal Innovation (NSI) is a medical device manufacturing company that develops and services med-tech devices that treat chronic pain. NSI is a Canadian registered corporation operating out of Mississauga, Ontario. Currently, NSI is developing the SONIK Monark 100 (SM-100) medical device that uses focused vibroacoustic therapy, a non-invasive and evidence-based clinical methodology, to treat back pain. The SM-100 has received Health Canada approval and is in the prototype testing phase. NSI is built upon the 20-years of key learnings from the “parent company”, KKT International which commercialized the predicate device, the KKT M2, in markets around the world. NSI owns exclusive rights to all IP and trade secrets for both KKT and NSI, and plans to commercialize the technology in the North American market/healthcare system.

Neuro Spinal Innovation (NSI) is proud to introduce the SONIK device, a ground-breaking treatment for among other things, back and neck pain. This non-invasive medical device delivers Accelerated Low-Frequency Kinetically Directed Impulses (ALKINDI waves) directly to the region of the body which has been damaged or compromised. The delivery of the ALKINDI waves through the SONIK device has been shown to positively influence gene expression…The era of deep healing has arrived. The SONIK Intelligence software and 3D diagnostics allow clinicians to build a personalized treatment protocol to address the root cause of pain and dysfunction.

The SONIK device is a patented, state-of-the-art medical device that is brilliantly designed with simplicity in mind. The device although tremendously sophisticated has been engineered to eliminate design complexities.

The SONIK device can be utilized in a hand-held configuration. This ground-breaking technology can be incorporated into every possible clinical environment.

The device delivers low-frequency impulses at the treatment site through painless contact with the skin. These impulses are delivered at a specific vector and are emitted through a probe. The remarkable outcomes which are visible to the eye, as well as experienced by the patients, have redefined our clinical expectations. Backed with numerous studies and global regulatory approvals, the SONIK treatment is well-equipped to revolutionize the world of chronic pain treatment.

Aslam  Khan

Aslam Khan

  • Chief Executive Officer (CEO)
  • Founder